CSL · 1 month ago
Director, R&D Architecture Lead
CSL Behring is a global biotherapeutics leader focused on saving lives through innovative therapies. The Director, R&D Architecture Lead will define and drive the digital architectural vision and strategy for R&D initiatives, ensuring the creation of scalable and secure systems that support cutting-edge research and product development.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Lead the design, development, and evolution of R&D systems architecture, including data pipelines, computational platforms, and integration frameworks
Collaborate with Digital Business Partners, scientists, engineers, and product teams to align architecture with R&D goals and overall business strategy
Evaluate emerging technologies and propose architectural innovations to enhance R&D productivity and enable next-generation research solutions
Ensure architectural compliance with security, scalability, and regulatory standards, ensuring systems meet operational and compliance requirements
Develop and maintain comprehensive architectural documentation, roadmaps, and reference models to guide development efforts
Mentor technical teams, promoting best practices in software and systems architecture across projects and teams
Partner with the I&T Enterprise Architecture team to define enterprise standards and ensure alignment of R&D roadmaps with CSL technology direction
Qualification
Required
Bachelor's or Master's degree in Computer Science, Engineering, or a related technical field
12+ years of experience in software or systems architecture, with at least 3 years in an R&D or innovation-driven environment
Strong understanding of cloud-native architectures, microservices, and data-intensive systems
Proficiency in architectural modeling tools and frameworks such as TOGAF, ArchiMate, or similar tools
Excellent communication and leadership skills, with the ability to engage cross-functional teams and communicate complex architectural concepts clearly
Preferred
Experience with R&D platforms in biotech, pharma, materials science, or related fields is a plus
Benefits
Health care
Financial protection
Emergency back up care
Summer camp
Mental health resources
Financial future planning
Charity matching contribution
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase